Novartis Pharmaceuticals

Erimos Pharmaceuticals is a biopharmaceutical company based in Houston, TX, dedicated to the discovery and development of small molecule therapeutics for the treatment of cancer and viral diseases. With a focus on innovative technology, Erimos aims to improve the lives and health outcomes of patients by inhibiting the expression of specific proteins over-expressed in cancer and demonstrating promising anti-viral results. As a privately-held company, Erimos has conducted multiple clinical trials with their lead product, Terameprocol, which has shown long-term tolerability, disease stability, and anti-tumor activities. With a portfolio of licensed patents and partnerships with leading institutions, Erimos is actively seeking collaborations to further develop and commercialize their clinical stage compound for various diseases, including solid tumors, hematological malignancies, pre-neoplastic conditions, and viral infections.Generated from the website

Takeda Pharmaceuticals in Morrisville, NC is a leading pharmaceutical company that focuses on developing innovative treatments for various medical conditions. With a commitment to improving patient outcomes, Takeda Pharmaceuticals conducts research and produces medications that address unmet medical needs. Generated from their business information

Viamet Metaverde LLC, led by Michael Von Irvin, RN BSN MBA, is an innovative hub focused on transforming healthcare education, safety, energy, and technology through a diverse range of cutting-edge ventures. With initiatives like Aivala.com for AI training in healthcare and Billionaires.University for wealth-building strategies, the company aims to address real-world challenges and enhance various industries. The organization is committed to leveraging artificial intelligence and operational excellence across multiple sectors, including fire protection and nuclear energy logistics. By uniting these ventures under Metaverde LLC, the company strives to create a lasting legacy of innovation while fostering connections among visionaries to shape the future. Generated from the website